WSE-bound biotech company OncoArendi Therapeutics plans to raise PLN 53-66 million from the planned IPO, the company prospectus showed. It plans to issue between 0.5-2 million new shares which represent up to 14.63 percent stake in the company. On top of that, the company will offer up to 11.67 million of existing shares. The company…